InsiderClue
Insiders · Profile

Seely Lynn

President and CEO at Lyell Immunopharma. Filing since 14 Mar 2025. CIK 0001327111

Company
Date
Role
Action
Shares
Amount
Of holding
LYEL Lyell Immunopharma, Inc.
21 Aug 2026
President and CEO
Sold at will
9,589
$149.01K
13.0%
LYEL Lyell Immunopharma, Inc.
10 Aug 2026
President and CEO
Sold at will
390
$5.59K
0.5%
LYEL Lyell Immunopharma, Inc.
11 May 2026
President and CEO
Sold at will
388
$7.34K
0.5%
LYEL Lyell Immunopharma, Inc.
11 Feb 2026
President and CEO
Sold at will
7,455
$174.37K
9.1%
LYEL Lyell Immunopharma, Inc.
10 Feb 2026
President and CEO
Sold at will
438
$10.13K
0.5%
LYEL Lyell Immunopharma, Inc.
10 Nov 2025
President and CEO
Sold at will
412
$6.64K
0.6%
LYEL Lyell Immunopharma, Inc.
21 Aug 2025
President and CEO
Sold at will
7,257
$76.52K
9.7%
LYEL Lyell Immunopharma, Inc.
12 Aug 2025
President and CEO
Sold at will
406
$4.20K
1.2%
LYEL Lyell Immunopharma, Inc.
11 Aug 2025
President and CEO
Sold at will
391
$4.12K
1.1%
LYEL Lyell Immunopharma, Inc.
14 Mar 2025
President and CEO
Bought
175,000
$106.19K
32.6%
10 decisions on file.